Oral Screening Report

More documents

Recommendations

Info

Oral Screening Report Methodology Methodology 148 volunteers were screened across two days at the Oncology Care Conference 2023 in London using the OralID device (Forward Science). This device aids visualisation of abnormalities of the oral mucosal such as cancer and pre-cancer by using fluorescence technology. The blue light is at a wavelength of 435–460 nm, allowing it to fluoresce green when shining on healthy tissue. When shining on abnormal tissue, the abnormality appears dark blue due to to a lack of fluorescent activity. This allows the clinician to observe abnormalities that may have otherwise been missed. Symptoms and risk factors for disease Prior to examination, volunteers were asked to complete a survey to identify their risk of oral cancers and whether they are experiencing any symptoms. This asked about their demographic (male or female); lifestyle choices such as whether the patient smoked, drank alcohol, or used chewing tobacco, Supari or Paan; and whether they experienced any symptoms of head and neck cancers or had a family history of these diseases. The survey also asked patients to input when they had last visited their GP and dentist and whether they attend regular visits to these healthcare professionals. Report of Day 1 Findings The morning of Day 2 of the conference saw The Swallows CEO, Chris Curtis, give a presentation entitled 'Oral screening in the fight against Head and Neck Cancer'. During this presentation, the statistics from the Day 1 activities of oral screening were presented and the audience was encouraged to go and be screened themselves.
Results and Findings Demographics Despite the fact that head and neck cancers disproportionately 1 affect males (71% cases male, 29% cases female ), only 18% of people who volunteered themselves for an oral screening were male. Male 18% Further research into whether this reluctance to come forward for screenings is observed in dentists and across the general public is important as it will inform awareness campaigns. The male demographic should be targeted in campaigns encouraging people to get oral cancer screenings due to the disproportionate effects of this disease based on sex. Female 82% Symptoms Prior to the screening, 2 in 5 people reported to be experiencing one of the listed symptoms. Lump in the neck 4% Bleeding (mouth, nose, ear) 7% Risk Factors Paan, Supari and CHewing Tobacco Just one volunteer said that they had tried Paan and Supari (less than 1% of volunteers) Change in VOice (hoarseness) Tooth or Gum Problems Ear ache or sore throat Sore or Ulcer in the mouth Red or white patch in the mouth 3% 18% 7% 7% 2% The survey that volunteers took before their screening also asked about their lifestyle habits and family history of disease which are risk factors for head and neck cancers. 8% of people said they had a family history of head and neck cancers (including oral cancer). Answered Yes Answered No Ye Regularly attend a GP SMoking Alcohol Regularly attend a dentist Despite 70% of people saying they regularly attended a dentist, only 52% of people reported visiting their dentist in the last year. 1. cancerresearchuk.org
Page 1: Oral Screening Report Introduction

Oral Screening Report

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?